GENE ONLINE|News &
Opinion
Blog

Eli Lilly
COVID-19: Eli Lilly Claims Efficacy, Seeks Speedy Emergency Use Authorization for Antibody Therapy
2020-10-09
Lilly’s Trailblazer Makes Headway in Breast Cancer Therapy
2020-09-23
The Evolution of Lung Cancer Therapies at a Glance
2020-04-16
Weekly Cover : Fosun and BioNTech Invest USD 135m for Covid-19 Vaccine
2020-03-19
Eli Lilly Gets FDA Breakthrough Status for Alopecia Drug
2020-03-17
GeneOnline’s Top Mergers and Acquisitions of 2019
2019-12-31
Weekly in Asia|Nov-3
2019-12-03
Weekly in Asia 2019|AUG-3
2019-08-25
Weekly in Asia 2019|JUL
2019-08-02
Kisqali Fulvestrant Combo Rejected by NICE for Breast Cancer Treatment in the UK
2019-05-02
Top 3 Announcements at the J.P. Morgan Healthcare Conference 2019
2019-01-13
Clash of three migraines medications & cost benefit for patients
2018-10-01
Fruquintinib becomes the first homegrown oncology drug approved in China for major indication
2018-09-11
1 2 3 4
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
EVENT
Scroll to Top